Home Tags Oxford BioTherapeutics

Tag: Oxford BioTherapeutics

World ADC 2018 Highlights

What to Expect at World ADC 2024 in London

What to Expect at World ADC 2024 in London

Menarini Ricerche and Oxford BioTherapeutics Progresses MEN1309 into the Clinic

A multi-center first-in-human clinical study to evaluate MEN1309, an antibody-drug conjugate for the treatment of metastatic solid cancers and non-Hodgkin's lymphoma, has been initiated...

X